KEVIN CHARLES GORMAN Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN CHARLES GORMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of KEVIN CHARLES GORMAN for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 32.99 | 864 | 28,503 | 3,031 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 19.59 | 7,142 | 139,912 | 0 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 32.99 | 864 | 28,503 | 3,031 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 8.65 | 10,199 | 88,221 | 0 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 19.59 | 7,142 | 139,912 | 0 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 8.66 | 16,551 | 143,332 | 0 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 8.65 | 10,199 | 88,221 | 0 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 5.76 | 23,168 | 133,448 | 0 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 8.66 | 16,551 | 143,332 | 0 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 32.99 | 864 | 28,503 | 404,957 | 404.1 K to 405 K (+0.21 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 5.76 | 23,168 | 133,448 | 0 | |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 19.59 | 7,142 | 139,912 | 404,093 | 397 K to 404.1 K (+1.80 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 32.99 | 864 | 28,503 | 404,957 | 404.1 K to 405 K (+0.21 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 8.65 | 10,199 | 88,221 | 396,951 | 386.8 K to 397 K (+2.64 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 19.59 | 7,142 | 139,912 | 404,093 | 397 K to 404.1 K (+1.80 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 8.66 | 16,551 | 143,332 | 386,752 | 370.2 K to 386.8 K (+4.47 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 8.65 | 10,199 | 88,221 | 396,951 | 386.8 K to 397 K (+2.64 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 5.76 | 23,168 | 133,448 | 370,201 | 347 K to 370.2 K (+6.68 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 8.66 | 16,551 | 143,332 | 386,752 | 370.2 K to 386.8 K (+4.47 %) |
| Jun 29 2018 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 5.76 | 23,168 | 133,448 | 370,201 | 347 K to 370.2 K (+6.68 %) |
| Jun 27 2018 | XNCR | Xencor Inc | GORMAN KEVIN CHARLES | Director | Option Exercise | A | 38.93 | 7,500 | 291,975 | 7,500 |